Abstract

The low pH of the stomach serves as a barrier to ingested microbes and must be overcome or bypassed when delivering live bacteria for vaccine or probiotic applications. Typically, the impact of stomach acidity on bacterial survival is evaluated in vitro, as there are no small animal models to evaluate these effects in vivo. To better understand the effect of this low pH barrier to live attenuated Salmonella vaccines, which are often very sensitive to low pH, we investigated the value of the histamine mouse model for this application. A low pH gastric compartment was transiently induced in mice by the injection of histamine. This resulted in a gastric compartment of approximately pH 1.5 that was capable of distinguishing between acid-sensitive and acid-resistant microbes. Survival of enteric microbes during gastric transit in this model directly correlated with their in vitro acid resistance. Because many Salmonella enterica serotype Typhi vaccine strains are sensitive to acid, we have been investigating systems to enhance the acid resistance of these bacteria. Using the histamine mouse model, we demonstrate that the in vivo survival of S. Typhi vaccine strains increased approximately 10-fold when they carried a sugar-inducible arginine decarboxylase system. We conclude that this model will be a useful for evaluating live bacterial preparations prior to clinical trials.

Highlights

  • Live recombinant attenuated Salmonella vaccines (RASVs) for humans are typically derived from Salmonella enterica serovar Typhi

  • Optimization of the histamine mouse model for bacterial gastric transit Previous work with the histamine mouse model has shown that maximal secretion of gastric acid occurs 45 min after the administration of histamine [34]

  • We chose to administer oral inoculations to mice 50 min after the injection of histamine to ensure that the incoming bacteria would enter a fully acidified gastric compartment

Read more

Summary

Introduction

Live recombinant attenuated Salmonella vaccines (RASVs) for humans are typically derived from Salmonella enterica serovar Typhi. Typhi is host restricted to humans, preclinical vaccine research and development relies on the closely related Salmonella enterica serovar Typhimurium as a model, since S. There are a number of important differences between the two serovars and the ways they interact with their respective hosts that, if not understood and addressed, can result in failure at the clinic. One such area that has been relatively overlooked is the impact of the gastric environment on vaccine viability and subsequent interactions with the host

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call